Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 USD | -0.73% | -4.42% | +56.31% |
May. 10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
May. 09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.31% | 1.6B | |
+51.09% | 63.85B | |
-2.21% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.55% | 26.52B | |
-21.47% | 18.69B | |
+3.03% | 12.73B | |
+21.93% | 12.11B | |
+27.92% | 12.07B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Edgewise Therapeutics Reports 'Positive' Two-Year Results From Becker Muscular Dystrophy Trial